Request for TOC Request for Sample
BUY NOW

Global Hyperhidrosis Treatment Market – Industry Trends and Forecast to 2030

Pharmaceutical | Upcoming Report | Nov 2022 | Global | 350 Pages | No of Tables: 220 | No of Figures: 60
Nucleus

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Global Hyperhidrosis Treatment Market

Market Size in USD Billion

CAGR :  %

USD 607.52 Million USD 939.45 Million 2022 2030
Forecast Period
2023 –2030
Market Size(Base Year)
USD 607.52 Million
Market Size (Forecast Year)
USD 939.45 Million
CAGR
%
Major Markets Players
  • GSK Plc
  • TheraVida
  • Revance .
  • NovaMedica.
  • UltheraInc.

Global Hyperhidrosis Treatment Market, By Type (Axillary Hyperhidrosis, Palmar Hyperhidrosis, plantar Hyperhidrosis), Treatment (Oral Medications, Over the Counter Antiperspirants, Surgery, Lasers, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Get Exclusive Sample Copy of this Report Here

Hyperhidrosis Treatment Market Analysis and Size

The hyperhidrosis treatment market is expected to witness significant growth during the forecast period. Hyperhidrosis is when the patient experiences extreme sweating issues independent of environmental conditions and thermoregulatory requirements. Over-the-counter antiperspirants are often the first line of defense for excessive sweating. Botulinum toxin type A is a safe and effective treatment for focal hyperhidrosis, which lasts longer than topical treatments and does not require invasive surgical procedures.

Data Bridge Market Research analyses a growth rate in the global hyperhidrosis treatment market in the forecast period 2023-2030. The expected CAGR of global Hyperhidrosis treatment market is tend to be around 5.60% in the mentioned forecast period. The market was valued at USD 607.52 million in 2022, and it would grow upto USD 939.45 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Hyperhidrosis Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Axillary Hyperhidrosis, Palmar Hyperhidrosis, plantar Hyperhidrosis), Treatment (Oral Medications, Over the Counter Antiperspirants, Surgery, Lasers, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

GSK Plc (U.K.), TheraVida (U.S.), Revance (U.S.)., NovaMedica. (Russia), Ulthera, Inc. (U.S.), DEMIRA e.V (Germany), Abbvie, Inc (U.S.), Fresh Tracks Therapeutics, Inc. (U.S.), Dr. August Wolff GmbH (Germany), Dermavant Sciences, Inc. (U.S.), Eirion Therapeutics, Inc (U.K.), Kaken Pharmaceutical Co., Ltd. (Japan), Intas Pharmaceuticals Ltd. (India), Roivant Sciences Ltd (Switzerland)

Market Opportunities

  • Increase in Hyperhidrosis Cases
  • Increasing Demand of Botox

Market Definition

Hyperhidrosis disorders are typically characterized by excessive sweating. The excess of sweat in this condition is not even certainly associated with heat or exercise; it is related or concerned to medical abnormality. The extreme sweat occurs in areas of the body such as underarms, palms, face; some people feel the sweat in their shoes and are also unrelated to body temperature. The major cause of the diseases could be the neurologic, endocrine, infectious and other systemic diseases, but healthy people are also likely to report the sufferings from Hyperhidrosis disorders.

Global Hyperhidrosis Treatment Market Dynamics

Drivers

  • Increasing Strategic Partnerships

The strategic partnerships and collaborations between several market players and associations are helping in the growth of the market. For instance, in April 2021, Fortress Biotech, partner company Journey Medicals, entered into a definitive agreement to acquire Qbrexza  in the USA from Dermira, a wholly-owned subsidiary of Eli Lilly. Therefore, the market is projected to witness growth. Though, the short-term results of cosmetic and therapeutic procedures are a major factor limiting the growth of the market.

  • Growing R&D Activities

The latest R&D activities associated with the market are gaining attraction globally. For instance, in October 2021, Brickell Biotech Inc. reported positive topline results from the Phase 3 pivotal Cardigan I and Cardigan II studies that evaluated sofpironium bromide gel, 15% as a once-daily topical formulation in patients having primary axillary hyperhidrosis. This boosts the market growth.

Opportunities

  • Increase in Hyperhidrosis Cases

As per the study published in National Library of Medicine by Jared Brackenrich in October 2021, In the U.S, the incidence of this disorder is projected to be around 3%. Emotional, psychological, social, and occupational impairment can all be caused by hyperhidrosis. Thus, growing burden of hyperhidrosis expected to boost the demand for its treatment thus increase the market growth.

  • Increasing Demand of Botox

According to the article published in International Hyperhidrosis Society of October 2020, Excessive sweating of the armpits, hands, feet, head, and face and other relatively small body areas can be treated with onabotulinumtoxin A. Botox has been shown to reduce sweating by 82-87%. The effects begin to show up 2 to 4 days post treatment, with the full effects generally appearing within two weeks. Dryness lasts 4 to 12 months on average, but few studies have found that it can last up to 14 months.

Restraints/Challenges

  • Side Effects of Botox

Several side effects are associated with botox. Effects such as muscle weakness, vision problems, breathing problems that are deeply affecting the patients and thus hampering the market growth.

  • High Cost

The huge expenditure of the treatment methods impede the market growth. Many times, due to lack of inappropriate payment plans and special considerations by the organizations, the patients fail to adapt these high-end treatment options which in return cost heavy impact on their health. Thus, this is an important restrain that needs to be taken care of.

This global hyperhidrosis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global Hyperhidrosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Hyperhidrosis Treatment Market

COVID-19 had a neutral impact on the market growth. According to the January 2021 published article titled, Paroxysmal hypothermia and hyperhidrosis with exacerbation after COVID‑19 infection, periods of hypothermia alternated with fever for four days. Although, after the recovery phase, episodic hyperhidrosis and hypothermia continued without fever despite the use of clonidine. Therefore, the demand for hyperhidrosis treatment has increased. According to the International Hyperhidrosis Society in May 2021, sweat could actually help prevent the transmission of COVID-19. Even in the post-pandemic era, the disease and its associated treatment continue rapidly.

Recent Development:

  • In May 2022, Meruho launched Rapifort Wipes in Japan, used for the treatment of primary axillary hyperhidrosis. It is the first prescription wipe preparation in the country.
  • In August 2021, Brickell Biotech, Inc. stated that the final patient had completed the Phase 3 pivotal Cardigan II study, which evaluates sofpironium bromide gel, 15% in patients with primary axillary  hyperhidrosis

Global Hyperhidrosis Treatment Market Scope

The global hyperhidrosis treatment market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Axillary Hyperhidrosis
  • Palmar Hyperhidrosis
  • Plantar Hyperhidrosis

Treatment

  • Oral Medications
  • Anticholinergics
  • Others
  • Over the Counter Antiperspirants
  • Surgery
  • Lasers
  • Others

Route of Administration

End-Users

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Hyperhidrosis Treatment Market Regional Analysis/Insights

The global hyperhidrosis treatment market is analysed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global Hyperhidrosis treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to favorable healthcare infrastructure, high per capita income, and high rate of adoption of advanced surgeries in the region.

Asia-Pacific dominates the market due to the promotion of research & development activities and awareness.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Hyperhidrosis Treatment Market Share Analysis

The global hyperhidrosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global hyperhidrosis treatment market.

Key players operating in the global hyperhidrosis treatment market include:

  • GSK Plc (U.K.)
  • TheraVida (U.S.)
  • Revance (U.S.)
  • NovaMedica. (Russia)
  • Ulthera, Inc. (U.S.)
  • DEMIRA e.V (Germany)
  • Abbvie, Inc (U.S.)
  • Fresh Tracks Therapeutics, Inc. (U.S.).
  • Dr. August Wolff GmbH (Germany)
  • Dermavant Sciences, Inc. (U.S.)
  • Eirion Therapeutics, Inc (U.K.)
  • Kaken Pharmaceutical Co., Ltd. (Japan)
  • Intas Pharmaceuticals Ltd. (India)
  • Roivant Sciences Ltd (Switzerland)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Testimonial
Claudio Rondena Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future